**4. Conclusions**

Stroke related to TAVR represents one of the most common and scary complications and is an independent risk factor that predicts morbidity and mortality; therefore, new strategies have been implemented to reduce its appearance. CPDs represent a novel strategy in stroke protection in patients undergoing TAVR. This evidence suggests that the use of CPD reduces the number and size of ischemic lesions identified on magnetic resonance; however, they are not yet established as a protective measure in the appearance of embolic phenomena and the reduction of ischemic lesions in TAVR patients. None of the devices we mainly studied managed to reduce the appearance of stroke; however, there was a reduction in the number of disabling strokes, which has an impact ultimately in a possible better quality of life.

*Cerebral Protection Devices in Transcatheter Aortic-Valve Replacement DOI: http://dx.doi.org/10.5772/intechopen.112661*
